Member Login
  1. Stocks
    2. /
  2. GSK (LSE: GSK)
    3. /

LSE:GSK (GSK)

About GSK

GlaxoSmithKline is one of the worlds leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

GSK (LSE: GSK) Latest News

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

The GSK share price is 14% off its 52-week high. Time to consider buying?

| Charlie Keough

The GSK share price has taken a tumble since peaking back in May. This Fool thinks now could be the…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

2 boring but beautiful picks I think could make great additions to a Stocks and Shares ISA

| Charlie Keough

This Fool thinks these two FTSE shares could be smart additions to bolster a Stocks and Shares ISA. Here, he…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

1 FTSE 100 bargain stock I love

| Kevin Godbold

I'm keen to add good-value FTSE 100 shares to my diversified portfolio and I reckon this one looks unmissable for…

Read more »

Senior couple are walking their dog through a public park in Autumn.
Investing Articles

These boring but beautiful picks will always have a place in my Stocks and Shares ISA

| Harvey Jones

Harvey Jones is building his Stocks and Shares ISA around seven FTSE 100 dividend stocks that should slowly reveal their…

Read more »

GSK scientist holding lab syringe
Investing Articles

As GSK’s share price drops 15%, should I buy, sell, or hold?

| Simon Watkins

GSK’s share price has fallen on negative developments for two of its drugs, but it still has a strong core…

Read more »

Businessman with tablet, waiting at the train station platform
Investing Articles

I’m considering 3 top UK dividend stocks for my portfolio this July

| Mark Hartley

Mark David Hartley is looking at adding a few dividend stocks to his portfolio this month. Will these three shares…

Read more »

Investing Articles

These 3 big-name FTSE 100 shares are stinking out my portfolio. Time to sell?

| Harvey Jones

Harvey Jones is reviewing three FTSE 100 shares trailing the rest of his portfolio and asks, do they still deserve…

Read more »

GSK scientist holding lab syringe
Investing Articles

Down 17%, does the GSK share price scream buy?

| Charlie Keough

It has been far from a smooth journey for the GSK share price recently. But this Fool likes the look…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

Here’s how I’d start investing in the stock market with a spare £800

| Christopher Ruane

Getting started in the stock market doesn't necessarily require thousands of pounds. Our writer explains how he'd start now on…

Read more »

A handsome mature bald bearded black man in a sunglasses and a fashionable blue or teal costume with a tie is standing in front of a wall made of striped wooden timbers and fastening a suit button
Investing Articles

3 recovering UK dividend shares – as picked by professionals

| Mark Hartley

Here are three UK dividend shares that top brokers and fund managers are either holding or have tipped this week.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

6.6% and 3.9% yields! 2 FTSE 100 stocks I’d snap up for juicy returns

| Sumayya Mansoor

On the hunt for consistent and growing dividends, our writer earmarks these two FTSE 100 stalwarts that could help her…

Read more »

Businessman with tablet, waiting at the train station platform
Market Movers

Is GSK’s share price a brilliant bargain after this new vaccines deal?

| Royston Wild

The GSK share price continues to weaken despite a major vaccines deal with German company CureVac. Is now the time…

Read more »